Matinas BioPharma Holdings (NYSE American: MTNB) shares plunged 68% from $1.93 to 62 cents Thursday after the company slashed its workforce 80% and began exploring strategic options that include potential sale of its lead pipeline candidate MAT2203, the Phase III-ready oral formulation of amphotericin B, and a wind down and dissolution of the company
These benefits are especially valuable for individuals with androgenetic alopecia as well as those aiming to prevent hair thinning
Instead, this peptide bypasses the vascular system and works directly on the nervous system
Susanne Brown, a woman who has been on Ozempic for four years, told Global News that Ozempic has been life-changing for her, and has allowed her to hit her fitness goals
Links to things we talked about in this episode: AG1 is offering new subscribers a FREE $76 gift when you sign up
Lina is a wellness tracker, not a medical device